Intrarectal administration of mCRAMP-encoding plasmid reverses exacerbated colitis in Cnlp−/− mice

[1]  S. Targan,et al.  Cathelicidin signaling via the Toll-like receptor protects against colitis in mice. , 2011, Gastroenterology.

[2]  Fiona Powrie,et al.  Intestinal homeostasis and its breakdown in inflammatory bowel disease , 2011, Nature.

[3]  R. Xavier,et al.  Genetics and pathogenesis of inflammatory bowel disease , 2011, Nature.

[4]  S. Itzkowitz,et al.  Intestinal inflammation and cancer. , 2011, Gastroenterology.

[5]  W. Strober,et al.  Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. , 2011, Gastroenterology.

[6]  L. Peyrin-Biroulet,et al.  Recent advances in cytokines: therapeutic implications for inflammatory bowel diseases. , 2011, World journal of gastroenterology.

[7]  W. Wu,et al.  Cathelicidins in inflammation and tissue repair: Potential therapeutic applications for gastrointestinal disorders , 2010, Acta Pharmacologica Sinica.

[8]  Y. Haikel,et al.  Antimicrobial Peptides Present in Mammalian Skin and Gut are Multifunctional Defence Molecules , 2010 .

[9]  J. Schulzke,et al.  Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications , 2007, Current opinion in gastroenterology.

[10]  W. Wu,et al.  A New Role for Cathelicidin in Ulcerative Colitis in Mice , 2007, Experimental biology and medicine.

[11]  H. Kawasaki,et al.  Naked gene therapy of hepatocyte growth factor for dextran sulfate sodium-induced colitis in mice. , 2006, Biochemical and biophysical research communications.

[12]  J. Meijerink,et al.  Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. , 2006, Gastroenterology.

[13]  R. Gallo,et al.  Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases , 2006, European journal of gastroenterology & hepatology.

[14]  E. Doménech.  Inflammatory Bowel Disease: Current Therapeutic Options , 2006, Digestion.

[15]  Y. Shai,et al.  Endotoxin (Lipopolysaccharide) Neutralization by Innate Immunity Host-Defense Peptides , 2006, Journal of Biological Chemistry.

[16]  J. Mathis,et al.  Reversal of experimental colitis disease activity in mice following administration of an adenoviral IL-10 vector , 2005, Journal of Inflammation.

[17]  P. Gibson,et al.  Reinforcing the mucus: a new therapeutic approach for ulcerative colitis? , 2005, Gut.

[18]  T. Strom,et al.  Tumor necrosis factor-α, interleukin-1β, and interleukin-6 expression in inflammatory bowel disease , 1992, Digestive Diseases and Sciences.

[19]  Katsuhiro Hayashi,et al.  Hepatocyte Growth Factor Facilitates Colonic Mucosal Repair in Experimental Ulcerative Colitis in Rats , 2003, Journal of Pharmacology and Experimental Therapeutics.

[20]  S. Leung,et al.  Cigarette smoke exposure increases ulcerative colitis-associated colonic adenoma formation in mice. , 2003, Carcinogenesis.

[21]  M. Kagnoff,et al.  Cell Differentiation Is a Key Determinant of Cathelicidin LL-37/Human Cationic Antimicrobial Protein 18 Expression by Human Colon Epithelium , 2002, Infection and Immunity.

[22]  Takaaki Ohtake,et al.  Innate antimicrobial peptide protects the skin from invasive bacterial infection , 2001, Nature.

[23]  Ji Ming Wang,et al.  Ll-37, the Neutrophil Granule–And Epithelial Cell–Derived Cathelicidin, Utilizes Formyl Peptide Receptor–Like 1 (Fprl1) as a Receptor to Chemoattract Human Peripheral Blood Neutrophils, Monocytes, and T Cells , 2000, The Journal of experimental medicine.

[24]  C. Cho,et al.  The role of polyamines in gastric mucus synthesis inhibited by cigarette smoke or its extract , 2000, Gut.

[25]  C. Cho,et al.  Involvement of neutrophils and free radicals in the potentiating effects of passive cigarette smoking on inflammatory bowel disease in rats. , 1999, Gastroenterology.

[26]  D. Hommes,et al.  Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). , 1995, Gastroenterology.

[27]  R. Newcombe,et al.  Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. , 1994, Gut.

[28]  H. Cooper,et al.  Clinicopathologic study of dextran sulfate sodium experimental murine colitis. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[29]  S. Ben‐Sasson,et al.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation , 1992, The Journal of cell biology.

[30]  A. Corfield,et al.  Mucin degradation in the human colon: production of sialidase, sialate O-acetylesterase, N-acetylneuraminate lyase, arylesterase, and glycosulfatase activities by strains of fecal bacteria , 1992, Infection and immunity.

[31]  M. Kobayashi,et al.  Enhanced mucosal cytokine production in inflammatory bowel disease. , 1992, Gastroenterology.